Related Experiment Video
Updated: Aug 10, 2026
06:56
Isolation of Double Negative αβ T Cells from the Kidney
Published on: May 16, 2014
Uremia-associated immune defect: the IL-10-CRP axis
Matthias Girndt1, Christof Ulrich, Harald Kaul
1Medical Department IV, University of the Saarland, Homburg/Saar, Germany. matthias.girndt@uniklinik-saarland.de
Kidney International. Supplement
|April 16, 2003
Summary
Interleukin-10 (IL-10) gene variations influence inflammation in end-stage renal disease (ESRD) patients. High IL-10 producers show reduced cardiovascular disease risk and mortality compared to low producers.
Area of Science:
- Nephrology
- Immunology
- Cardiovascular Medicine
Background:
- Systemic inflammation is linked to unstable atherosclerotic disease.
- End-stage renal disease (ESRD) patients exhibit chronic elevation of pro-inflammatory cytokines.
- Activated monocytes/macrophages infiltrating atherosclerotic plaques contribute to disease progression.
Purpose of the Study:
- To investigate the role of interleukin-10 (IL-10) in modulating inflammation in hemodialysis (HD) patients.
- To explore the genetic influence of IL-10 single nucleotide polymorphisms (SNPs) on inflammation and cardiovascular disease (CVD) risk in ESRD.
Main Methods:
- Analysis of monocyte activation levels in healthy individuals versus dialysis patients.
- Assessment of IL-10's protective role against inflammation in HD patients.
- Correlation of IL-10 gene promoter SNPs with C-reactive protein (CRP) levels and CVD outcomes.
Main Results:
- Dialysis patients show significantly higher monocyte activation (50%) compared to healthy individuals (15-20%).
- IL-10 demonstrates a protective effect against systemic inflammation in HD patients.
- IL-10 genotype influences CRP levels and predicts CVD risk, with high-producer genotypes associated with lower event rates and mortality.
Conclusions:
- IL-10 genotype heterogeneity explains variability in limiting uremia- and dialysis-induced inflammation.
- IL-10 genotype serves as a predictive marker for cardiovascular disease risk and mortality in ESRD patients.
- Targeting IL-10 pathways may offer therapeutic strategies for reducing cardiovascular complications in ESRD.
Related Concept Videos
01:24T Cell Types and Functions
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
01:25Immunodeficiency Diseases
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
There are three main causes of immunodeficiency disorders...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
01:20Inflammatory Bowel Disease II: Ulcerative Colitis
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
01:25Inflammatory Bowel Disease III: Crohn's Disease
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...